Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3A | P49840 | 6/20 | 0.41 |
| ▸ | GSK3B | P49841 | 6/20 | 0.41 |
| ▸ | LTK | P29376 | 2/20 | 0.41 |
| ▸ | ALK | Q9UM73 | 2/20 | 0.41 |
| ▸ | DYRK1B | Q9Y463 | 2/20 | 0.41 |
| ▸ | RET | P07949 | 1/20 | 0.41 |
| ▸ | MET | P08581 | 1/20 | 0.41 |
| ▸ | GRK5 | P34947 | 1/20 | 0.41 |
| ▸ | CDK8 | P49336 | 1/20 | 0.41 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.41 |
| ▸ | MST1R | Q04912 | 1/20 | 0.41 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.41 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.41 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.41 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.41 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.38 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.38 |
| ▸ | ABL1 | P00519 | 1/20 | 0.38 |
| ▸ | PRKACA | P17612 | 1/20 | 0.38 |
| ▸ | KDR | P35968 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25384850 | 0.81 | GSK3A (0.41) | GSK3AGSK3BLTKALKDYRK1B | |
| SCHEMBL1534623 | 0.76 | LTK (0.44) | GSK3AGSK3BLTKALKDYRK1B | |
| SCHEMBL4476188 | 0.76 | LTK (0.44) | GSK3AGSK3BLTKALKDYRK1B | |
| SCHEMBL1855620 | 0.73 | LTK (0.60) | GSK3AGSK3BLTKALKDYRK1B | |
| SCHEMBL1534586 | 0.71 | LTK (0.54) | GSK3AGSK3BLTKALKDYRK1B | |
| SCHEMBL20772448 | 0.69 | LTK (0.44) | GSK3AGSK3BLTKALKDYRK1B | |
| SCHEMBL4476775 | 0.69 | LTK (0.44) | GSK3AGSK3BLTKALKDYRK1B | |
| SCHEMBL24508618 | 0.67 | EGFR (0.33) | GSK3AGSK3BDYRK1ACLK4KDR | |
| SCHEMBL17408735 | 0.65 | LTK (0.58) | GSK3AGSK3BLTKALKDYRK1B | |
| SCHEMBL24508616 | 0.64 | L3MBTL1 (0.39) | DYRK1ANQO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019043635-A1 | D-AMINO ACID OXIDASE ACTIVITY INHIBITING COMPOUNDS | RICHTER GEDEON NYRT. (HU) | 2019-03-07 | — | — | WO | claimed |
| WO-2019043635-A1 | D-AMINO ACID OXIDASE ACTIVITY INHIBITING COMPOUNDS | RICHTER GEDEON NYRT. (HU) | 2019-03-07 | — | — | WO | disclosed |
| US-8546376-B2 | Pharmaceutical compounds | ALMAC DISCOVERY LIMITED (GB) | 2013-10-01 | — | — | US | disclosed |
| US-20120238541-A1 | PHARMACEUTICAL COMPOUNDS | ALMAC DISCOVERY LIMITED (GB) | 2012-09-20 | — | — | US | disclosed |
| EP-2473495-A1 | PHARMACEUTICAL COMPOUNDS | Almac Discovery Limited (GB) | 2012-07-11 | — | — | EP | disclosed |
| WO-2011033265-A1 | PHARMACEUTICAL COMPOUNDS | ALMAC DISCOVERY LIMITED (GB) | 2011-03-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120238541-A1 | PHARMACEUTICAL COMPOUNDS | PIK3CA, PLK1, MTOR | GSK3A 10/4885GSK3B 9/4885LTK 508/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.